New ALS Treatment, AMX0035, No Evidence of Benefit, FDA Panel Finds
The primary objective was to slow the decline on a 48-point ALS scale with 12 physical skills, including walking, speaking, swallowing, dressing, handwriting, and breathing.… Read More »New ALS Treatment, AMX0035, No Evidence of Benefit, FDA Panel Finds